Risk Stratification and Antiarrhythmic Drug Therapy.
In: Arrhythmogenic RV Cardiomyopathy/Dysplasia; 2007, p171-179, 9p
Online
Buch
Zugriff:
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an important cause of ventricular tachyarrhythmias and sudden death in young patients and athletes with apparently normal hearts. The disease is characterized by localized or diffuse atrophy of predominantly right ventricular myocardium with subsequent replacement by fatty and fibrous tissue. As a result of these pathomorphological alterations, global and regional right (and left) ventricular dysfunction and ventricular tachyarrhythmias due to areas of slow conduction and dispersion of refractoriness are the major clinical findings and manifestations of ARVC/D [1-4]. [ABSTRACT FROM AUTHOR]
Copyright of Arrhythmogenic RV Cardiomyopathy/Dysplasia is the property of Springer eBooks and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Risk Stratification and Antiarrhythmic Drug Therapy.
|
---|---|
Autor/in / Beteiligte Person: | Markus, Frank I. ; Nava, Andrea ; Thiene, Gaetano ; Wichter, Thomas ; Corrado, Domenico ; Paul, Matthias |
Link: | |
Quelle: | Arrhythmogenic RV Cardiomyopathy/Dysplasia; 2007, p171-179, 9p |
Veröffentlichung: | 2007 |
Medientyp: | Buch |
ISBN: | 978-88-470-0489-4 (print) |
DOI: | 10.1007/978-88-470-0490-0_19 |
Sonstiges: |
|